본문

  1. Home
5 Results:AA:RALSTON L PP:ELSEVIER INC 0.77 sec.
RSS 
Multilingual
 Расширенный поиск
 Новый поиск книги прибытия
Selected Print Select Export to Excel
1
Advances in the molecular pharmacology and therapeutics of bone disease and International Symposium on Paget’s Disease July 10–14, 2007 St. Catherine’s College, Oxford, UK
Advances in the molecular pharmacology and therapeutics of bone disease and International Symposium on Paget’s Disease July 10–14, 2007 St. Catherine’s College, Oxford, UK
Martin, T. J., | Elsevier Inc | 2007 ,
2
The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo
The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo
Idris, A. I., | Elsevier Inc | 2010 ,
3
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: The GENOMOS study
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: The GENOMOS study
Langdahl, B. L., | Elsevier Inc | 2008 ,
4
Pathogenesis of Paget's disease of bone
Pathogenesis of Paget's disease of bone
Ralston, S. H., | Elsevier Inc | 2008 ,
5
Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone
Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone
Gavin J. A. Lucas., | Elsevier Inc | 2006 ,
처음1마지막